March 20 ,2009 - One of the current controversies in the field of adult congenital heart disease is whether patients should be cared for at an adult or pediatric facility and by an adult or pediatric heart surgeon, and a new study published in the March issue of the Annals of Thoracic Surgery evaluates this issue.

March 20, 2009 - BRAHMS AG of Hennigsdorf, Germany and Annapolis, MD, recently submitted a 510(k) file to the FDA to market its patented BRAHMS MR-proANP Kryptor Test used to find biomarkers for heart failure.

March 19, 2009 - Boston Scientific Corp. today announced the launch of its iCross Coronary Imaging Catheter, a product designed to improve the deliverability of the company's intravascular ultrasound (IVUS) technology, the iLab Ultrasound Imaging System.


Endovascular repair for aortic aneurysms has gained popularity in the past five to six years as physicians has learned how to use and became more comfortable with the new generations of stent graft technology.

March 19, 2009 - Sorin Group and Orange Business Services today entered into an agreement to develop and service a remote monitoring solution for patients implanted with cardiac rhythm management (CRM) devices.

March 19, 2009 – The 18th annual Interventional Cardiology Symposium will take place June 18-20 in Montreal, Canada.

March 19, 2009 - The Drug Information Association (DIA), in cooperation with the Heart Rhythm Society (HRS) and the FDA, will host Cardiovascular Safety and QT/Arrhythmia Assessment in Drug Development: Optimizing Drug Development Wednesday, April 29 – Friday, May 1 in Bethesda, MD.

March 19, 2009 – The Society of Nuclear Medicine (SNM) will host a two-day symposium Thursday, April 30–Friday, May 1 focused on advances in stem cell therapy, leading-edge research in imaging technology and targeted imaging of the cardiovascular system, including imaging of cardiovascular receptors, vascular biology, myocardial metabolism and myocardial repair.

March 19, 2009 - Sanofi-aventis said yesterday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-3 in favor of the approval of Multaq (dronedarone) to treat patients with non-permanent atrial fibrillation (AF).

March 19, 2009 – Led by Senator Richard Durbin (D-IL) and Congressman Zack Space (D-OH), the federal government yesterday introduced new legislation that will address the needs of those affected by congenital heart defects (CHDs).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now